Shahad A. Alshehri

Shahad A. Alshehri

Auto-generated profile, based on publicly available information

Shahad A. Alshehri

College of Medicine, University of Jeddah, Jeddah, Saudi Arabia

Research Focus & Metrics

Academic Career Length

2Years (2025-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
5 June 2025 in Saudi Journal of Health Systems Research
Verified
Journal Article
Open access
AAAbdullah S. Algarni
Abdullah S. Algarni
SAShahad A. Alshehri
Shahad A. Alshehri
AAAtyaf F. Alzahrani
Atyaf F. Alzahrani
AAAhlam S. Almuabdi
Ahlam S. Almuabdi
SASafinaz M. Alshiakh
Safinaz M. Alshiakh
RSRamy Samargandi
Ramy Samargandi
Introduction Human factors (HF) are essential in healthcare, particularly for enhancing patient safety and minimizing errors. Globally, initiatives like AHRQ and GMC highlight the importance of HF in medical education to enhance patient safety, yet limited research exists on HF awareness among Saudi medical students. This study aims to assess HF awareness and the role of HF education in promoting patient safety among medical students and interns in Jeddah, Saudi Arabia. Methodology This observational cross-sectional study in Jeddah, Saudi Arabia, surveyed medical students and interns on HF awareness and skills. Data were collected via Google and analyzed via IBM SPSS 29.0.0. Results Our study included 676 participants, mostly female (57.2%), with the largest group from the University of Jeddah (53.4%). Over half had excellent academic performance (54.3%). Awareness of HF was reported by 60.5% and was significantly associated with university affiliation (p<0.001), academic year (p=0.003), and academic performance (p<0.001). Non-technical skills (NTS) training was reported by 81.1%, mainly in communication (70.6%). Confidence was highest in teamwork (55.0% extremely confident) and lowest in challenging authority (29.1%). Confidence levels were significantly associated with gender (p<0.001), university (p=0.002), academic year (p=0.015), and academic performance (p<0.001). Conclusion Our study highlights a generally moderate-to-high level of awareness of HF and a high level of appreciation for NTS among participants, with variations influenced by gender, university affiliation, academic level, and academic performance. Emphasizing early integration of HF and employing diverse teaching methods could enhance the effectiveness of NTS training in medical education.

19 June 2026 in Annals of Middle Eastern Medicine
Verified
Journal Article
Closed access
SASara Mahfoud Alghamdi
Sara Mahfoud Alghamdi
MAMohammed A. Alahmadi
Mohammed A. Alahmadi
AAAhmed K Alsaif
Ahmed K Alsaif
LALama S Alghamdi
Lama S Alghamdi
SAShahad A Alshehri
Shahad A Alshehri
AAAbdullah Algarni
Abdullah Algarni
Chronic inflammatory skin diseases, including psoriasis and atopic dermatitis, are associated with an increased risk of cardiovascular disease (CVD), largely due to systemic inflammation. Biologic therapies that target key inflammatory cytokines have shown promise not only in improving skin outcomes but also in potentially modifying cardiovascular risk. This study aims to evaluate the impact of biologic treatments used in dermatology on CVD risk through a systematic review and single-arm meta-analysis. Databases including PubMed, Google Scholar, Web of Science, Medline, Scopus, Wiley, EBSCO, and ScienceDirect were searched for studies reporting cardiovascular outcomes in patients receiving biologics for dermatologic conditions. Eligible studies included randomized controlled trials (RCTs), observational cohorts, and case series. Cardiovascular outcomes assessed included major adverse cardiovascular events (MACE), myocardial infarction, stroke, and changes in cardiovascular risk factors. A total of 21 studies were included. The pooled proportion of patients experiencing cardiovascular outcomes after biologic therapy was 7.82% (95% CI: 5.31%–11.37%) under the random-effects model. A modest but significant correlation (r = 0.2051, p = 0.0126) between biologics and cardiovascular benefit was observed. Sensitivity analyses supported the robustness of findings. Risk of bias ranged from low to moderate. Biologic therapies in dermatology, particularly TNF-α, IL-17, and IL-23 inhibitors, may reduce cardiovascular risk through systemic inflammation suppression. However, heterogeneity, publication bias, and a predominance of observational data limit the strength of conclusions. Further RCTs are needed to confirm these findings.